Biotricity, Inc. (BTCY)
OTCMKTS · Delayed Price · Currency is USD
0.0953
-0.0297 (-23.76%)
Jul 31, 2026, 11:42 AM EST
Biotricity Revenue
In the fiscal year ending March 31, 2026, Biotricity had annual revenue of $16.00M with 16.01% growth. Biotricity had revenue of $4.25M in the quarter ending March 31, 2026, with 14.80% growth.
Revenue
16.00M
Revenue Growth
+16.01%
P/S Ratio
0.14
Revenue / Employee
347.79K
Employees
46
Market Cap
2.23M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 16.00M | 2.21M | 16.01% |
| Mar 31, 2025 | 13.79M | 1.73M | 14.32% |
| Mar 31, 2024 | 12.06M | 2.42M | 25.15% |
| Mar 31, 2023 | 9.64M | 1.99M | 26.00% |
| Mar 31, 2022 | 7.65M | 4.27M | 126.02% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Fuse Medical | 18.40M |
| Allurion Technologies | 12.60M |
| Escalon Medical | 11.45M |
| ADM Tronics Unlimited | 3.35M |
| Vycor Medical | 1.89M |
| Holdco Nuvo Group D.G | 176.00K |
| REMSleep Holdings | 16.72K |
| Ludwig Enterprises | 207.00 |
Biotricity News
- 17 days ago - Biotricity Annual report: Q4 2026 - Filings
- 2 months ago - Biotricity Transcript: 16th Annual LD Micro Invitational Conference - Transcripts
- 2 months ago - Biotricity, Inc to Present at the LD Micro Invitational XVI - Newsfile Corp
- 6 months ago - Biotricity Earnings Call Transcript: Q3 2026 - Transcripts
- 6 months ago - Biotricity Earnings release: Q3 2026 - Filings
- 6 months ago - Biotricity Quarterly report: Q3 2026 - Filings
- 6 months ago - Biotricity Delivers Strong Q3 Fiscal 2026 Performance, Growing Revenue Momentum and Expanding EBITDA - GlobeNewsWire
- 6 months ago - Biotricity to Announce Continued Growth in Fiscal 2026 Third Quarter Financial Results and Business Update Call on February 11th - GlobeNewsWire